New Anti Diabetes Drug Available in American Pharmacies

Tue, 14 Feb 2012
A recently approved type 2 diabetes drug Bydureon, manufactured by Amylin Pharmaceuticals and Alkermes plc, is currently available by prescription in American pharmacies.

Bydureon is a forerunner as it is the only once a week type 2 diabetes treatment . The FDA approved it on 27 January 2012 in addition to diet and exercise in order to assist glycaemic control type 2 diabetic adults.

The approval has been based on safety and efficacy data from the period of time the clinical trial programme lasted, where Bydureon improved glycaemic control in a once a week dose.

Bydureon comes in a easy to use single-dose tray in order that diabetics can self-administer the subcutaneous injection once a week.

To enable diabetics to start off successfully, Amylin provides Bydureon Steady Support for diabetics and healthcare providers.

Bydureon Steady Support offers flexible resources for healthcare providers and their patients to learn about Bydureon, its administration and how to sign up to receive ongoing support with type 2 diabetes management .

Link to this page

Copy and Paste the following HTML into your page.